Merck’s (MRK) Hopes Crushed

Posted: April 28, 2008 at 5:49 pm

Print Email


Merck (MRK) had high hopes for its cholesterol drug Cordaptive

According to The Wall Street Journal, things did not work out. The paper reports that the agency issuing a "not approvable" letter for the potential blockbuster.

Douglas A. McIntyre

RSS Facebook Twitter
Read more: Pharmaceuticals,